The Role of Global Health Partnerships in Infectious Disease Control: Lessons from Indonesia’s Response to Tuberculosis and COVID-19
DOI:
https://doi.org/10.30994/jgrph.v10i1.558Keywords:
Tuberculosis, COVID-19, Indonesia, Global Health Partnership, Infectious Disease PolicyAbstract
Indonesia's dual burden of tuberculosis and COVID-19 has highlighted the critical role of global health partnerships in strengthening infectious disease control. This study examines how collaborations with organizations such as WHO, the Global Fund, and USAID have supported Indonesia's response, particularly in TB detection, case management, and pandemic adaptation. A qualitative literature review was conducted, analyzing ten peer-reviewed studies published between 2020 and 2025. The findings reveal that while global partnerships facilitated knowledge transfer, financial assistance, and digital innovation, challenges persist in coordination, private sector integration, and policy alignment. The study concludes that sustained commitment, institutional capacity, and harmonized
governance are essential to maximize the impact of international cooperation on national disease control strategies.
Downloads
References
Ahmada, S. F. (2024). Indonesia Interest toward G20 Pandemic Fund: Global Health Diplomacy Perspective. In Saqib Fardan Ahmada Jurnal Hubungan Internasional □ (Vol. 17, Issue 1).
Asep Setiawan, D. A. N. F. T. (2022). Indonesia’s Global Health Diplomacy in The Time of Covid-19 Pandemic. Journal of Social Political Sciences.
Bhatia, V., Mandal, P. P., Satyanarayana, S., Aditama, T. Y., & Sharma, M. (2020). Mitigating the impact of the COVID-19 pandemic on progress towards ending tuberculosis in the WHO South-East Asia Region. WHO South-East Asia Journal of Public Health, 9(2), 95–99. https://doi.org/10.4103/2224-3151.294300
Caren, G. J., Iskandar, D., Pitaloka, D. A. E., Abdulah, R., & Suwantika, A. A. (2022). COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia. In Journal of Multidisciplinary Healthcare (Vol. 15, pp. 175–183). Dove Medical Press Ltd. https://doi.org/10.2147/JMDH.S341130
Filip, R., Gheorghita Puscaselu, R., Anchidin-Norocel, L., Dimian, M., & Savage, W. K. (2022). Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems. In Journal of Personalized Medicine (Vol. 12, Issue 8). MDPI. https://doi.org/10.3390/jpm12081295
Goletti, D., Delogu, G., Matteelli, A., & Migliori, G. B. (2022). The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. International Journal of Infectious Diseases, 124, S12–S19. https://doi.org/10.1016/j.ijid.2022.02.047
KATO, A. (2024). Development and Challenges of Infectious Disease Control Measures in Trade Policy Using COVID-19-related Medical Resources as a Case Study. Public Policy Review, 20(4), 1–25. https://doi.org/10.57520/PRIPPR.20-4-3
Loutsou, M., Georgakopoulou, V. E., Roussakis, N., Chadia, K., & Steiropoulos, P. (2024). Miliary TB and COVID-19 Coinfection in a Patient With a History of Post-polycythemia Vera Myelofibrosis Treated With Ruxolitinib: A Case Report. Cureus. https://doi.org/10.7759/cureus.63791
Motta, I., Boeree, M., Chesov, D., Dheda, K., Günther, G., Horsburgh, C. R., Kherabi, Y., Lange, C., Lienhardt, C., McIlleron, H. M., Paton, N. I., Stagg, H. R., Thwaites, G., Udwadia, Z., Van Crevel, R., Velásquez, G. E., Wilkinson, R. J., & Guglielmetti, L. (2024). Recent advances in the treatment of tuberculosis. In Clinical Microbiology and Infection (Vol. 30, Issue 9, pp. 1107–1114). Elsevier B.V. https://doi.org/10.1016/j.cmi.2023.07.013
Peraturan BPK. (2017). Peraturan Menteri Kesehatan Nomor 67 Tahun 2016 Penanggulangan Tuberkulosis.
Pralambang, S. D., & Setiawan, S. (2021). Faktor Risiko Kejadian Tuberkulosis di Indonesia. Jurnal Biostatistik, Kependudukan, Dan Informatika Kesehatan, 2(1). https://doi.org/10.7454/bikfokes.v2i1.1023
Sadewa, D. P. (2024). Global Health in International Relations: State Actors’ Response to COVID-19. Jurnal Lemhannas RI, 12(2), 187–202. https://doi.org/10.55960/jlri.v12i2.519
Sassi, A., Lestari, B. W., El Muna, K. U. N., Oga-Omenka, C., Afifah, N., Widarna, R., Huria, L., Aguilera Vasquez, N., Benedetti, A., Hadisoemarto, P. F., Daniels, B., Das, J., Pai, M., & Alisjahbana, B. (2024). Impact of the COVID-19 pandemic on quality of tuberculosis care in private facilities in Bandung, Indonesia: a repeated cross-sectional standardized patients study. BMC Public Health, 24(1). https://doi.org/10.1186/s12889-023-17001-y
Subekti, R., Diva, A., Suprayoga, A., & Violie, L. N. (2023). Cooperation World Health Organization Member in Handling Covid-19. 72–80. https://doi.org/10.2991/978-94-6463-206-4_11
Vasquez, N. A., Oga-Omenka, C., Yellappa, V., Lestari, B. W., Sassi, A., Sheokand, S., Olusola-Faleye, B., Huria, L., Brubacher, L. J., Baruwa, E., Alisjahbana, B., & Pai, M. (2025). COVID-19 policies and tuberculosis services in private health sectors of India, Indonesia, and Nigeria. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 38, 100503. https://doi.org/10.1016/j.jctube.2024.100503
WHO. (2024). COVID-19 epidemiological update – 19 January 2024.
Widarna, R., Afifah, N., Djunaedy, H. A. K., Sassi, A., Vasquez, N. A., Oga-Omenka, C., Salindri, A. D., Lestari, B. W., Pai, M., & Alisjahbana, B. (2024). The shifting landscape of private healthcare providers before and during the COVID-19 pandemic: Lessons to strengthen the private sectors engagement for future pandemic and tuberculosis care. PLOS Global Public Health, 4(10), e0003112. https://doi.org/10.1371/journal.pgph.0003112
Yassin, M. A., Kimbo, L., Wandwalo, E., Rashid, A., Dzokoto, A., Weber, U., & Stallworthy, G. (2024). Leveraging Global Fund’s investments to expand innovative public-private provider engagement in TB. IJTLD OPEN, 1(6), 250–257. https://doi.org/10.5588/IJTLDOPEN.24.0162
